In addition to its current liver tumor indication, HistoSonics is pursuing future indications across multiple applications including kidney, pancreas, prostate, neuro, women's health, and other significant underserved human health areas, to realize the broader potential histotripsy across multiple disease states and medical specialties. This role drives cross-functional alignment across software engineering, quality, regulatory, product development, and systems engineering teams to deliver software releases and supporting documentation that meet business objectives, regulatory requirements, and program milestones.